Metformin and sitagliptin and Moxetumomab Pasudotox-tdfk
Determining the interaction of Metformin and sitagliptin and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: metformin / sitagliptin
Brand name: Janumet, Janumet XR
Synonyms: Sitagliptin and Metformin
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Metformin and sitagliptin-Moxetumomab pasudotox-tdfk Intravenous
- Metformin and sitagliptin-Moxifloxacin
- Metformin and sitagliptin-Moxifloxacin (Systemic)
- Metformin and sitagliptin-Moxifloxacin Hydrochloride
- Metformin and sitagliptin-Moxifloxacin Injection
- Metformin and sitagliptin-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Metformin Extended-Release Tablets
- Moxetumomab Pasudotox-tdfk-Metformin Hydrochloride
- Moxetumomab Pasudotox-tdfk-Metformin Oral Solution
- Moxetumomab Pasudotox-tdfk-Metformin Tablets
- Moxetumomab Pasudotox-tdfk-Methacholine
- Moxetumomab Pasudotox-tdfk-Methadone